Journal of the American Society of Hypertension
Volume 3, Issue 1 , Pages 42-51 , January 2009

Advances in noninvasive methods for functional evaluation of renovascular disease

  • Lucas S. Aparicio, MD

      Affiliations

    • Department of Internal Medicine, Hypertension Area, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
    • Corresponding Author InformationCorresponding author: Lucas S. Aparicio, MD, Department of Internal Medicine, Hypertension Area, Hospital Italiano de Buenos Aires, Gascon 450 (C1181ACH), Buenos Aires, Argentina. Tel: +54 11 4959 0200; fax: +54 11 4958 4454
    • ,
  • Gaston F. Boggio, MD

      Affiliations

    • Department of Internal Medicine, Hypertension Area, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
    • ,
  • Gabriel D. Waisman, MD

      Affiliations

    • Department of Internal Medicine, Hypertension Area, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
    • ,
  • Juan C. Romero, MD

      Affiliations

    • Division of Nephrology and Hypertension, Mayo College of Medicine, Rochester, Minnesota, USA

Received 14 June 2008 ,Accepted 28 August 2008.

References 

  1. Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull. 2005;74:35–55
  2. Simon P, Benarbia S, Charasse C, Stanescu C, Boulahrouz R, Lee Cacheux P, et al. [Ischemic renal diseases have become the most frequent causes of end stage renal disease in the elderly]. Arch Mal Coeur Vaiss. 1998;91:1065–1068
  3. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure?. Ann Rev Med. 2001;52:421–442
  4. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996–2000. Am J Roentgenol. 2004;183:561–568
  5. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145:901–912
  6. AHRQ Publication No 07-EHC004-EF. 2006;
  7. Sacks D, Murphy TP. Percutaneous renal revascularization and medical coverage. Endovascular Today. 2007;6:28–34
  8. Mistry S, Ives N, Harding J, Fitzpatrick-Ellis K, Lipkin G, Kalra PA, et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens. 2007;21:511–515
  9. Kalra PA. The impact of renal artery revascularisation in atherosclerotic renovascular disease: the Angioplasty and Stenting for Renal Artery Lesions (ASTRAL) trial, in XLV ERA-EDTA CONGRESS. 2008;Stockholm, Sweden.
  10. Bax L, Mali WP, Buskens E, Koomans HA, Beutler JJ, Braam B, et al. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery (The STAR-study: rationale and study design). J Nephrol. 2003;16:807–812
  11. US Renal data System, USRDS 2004 Annual Data Report, A.o.E.S.R.D.o.t.U. States, Editor. National Institute of Health, National Institute of Diabetes, Digestive and Kidney Diseases: Bethesda, Maryland; 2004;
  12. Dworkin LD. CORAL Protocol Summary. 2005;http://www.coralclinicaltrail.org/public/CORALProtocol_v4.pdfAccessed: December 20, 2007
  13. Wilcox CS. Ischemic nephropathy: noninvasive testing. Semin Nephrol. 1996;16:43–52
  14. Stamley T. Renovascular Hypertension. Baltimore, Maryland: The Williams & Wilkins Co; 1963;232
  15. Gomez I. Noninvasive estimations of distal nephron function in experimental renal vascular hypertension. Forthcoming.
  16. De Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, Bartunek J, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–1855
  17. Heptinstall R. Hypertension II: secondary forms. In:  Heptinstall RM editors. Pathology of the Kidney. Boston, Massachusetts: Little, Brown & Co; 1992;p. 1029–1095
  18. Cantin M, Solymoss B, Benchimol S, Desormeaux Y, Langlais J, Ballak M, et al. Metaplastic and mitotic activity of the ischemic (endocrine) kidney in experimental renal hypertension. Am J Pathol. 1979;96:545–565
  19. Textor SC. Ischemic nephropathy: where are we now?. J Am Soc Nephrol. 2004;15:1974–1982
  20. Wilson C, Floyer MA. The Kidney: Morphology, Biochemistry, Physiology. New York, New York: Rouiller & Muller; 1971;155–76
  21. Zeller T, Bonvini RF, Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv. 2008;71:995–999
  22. Soulez G, Therasse E, Qanadli SD, Froment D, Leveille M, Nicolet V, et al. Prediction of clinical response after renal angioplasty: respective value of renal Doppler sonography and scintigraphy. Am J Roentgenol. 2003;181:1029–1035
  23. Radermacher J. Echo-Doppler to predict the outcome for renal artery stenosis. J Nephrol. 2002;15:S69–S76
  24. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410–417
  25. Garcia-Criado A, Gilabert R, Nicolau C, Real MI, Muntaña X, Blasco J, et al. Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med. 2005;24:1641–1647
  26. Zeller T, Muller C, Frank U, Burgelin K, Horn B, Schwarzwalder U, et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv. 2003;58:510–515
  27. Opdenakker L, Oyen R, Vervloessem I, Goethuys H, Baert AL, Baert LV, et al. Acute obstruction of the renal collecting system: the intrarenal resistive index is a useful yet time-dependent parameter for diagnosis. Eur Radiol. 1998;8:1429–1432
  28. Patriquin HB, O'Regan S, Robitaille P, Paltiel H. Hemolytic-uremic syndrome: intrarenal arterial Doppler patterns as a useful guide to therapy. Radiology. 1989;172:625–628
  29. Hollenbeck M, Hilbert N, Meusel F, Grabensee B. Increasing sensitivity and specificity of Doppler sonographic detection of renal transplant rejection with serial investigation technique. Clin Investig. 1994;72:609–615
  30. Riehl J, Schmitt H, Bongartz D, Bergmann D, Sieberth H. Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant. 1997;12:1608–1614
  31. Miller ED, Samuels AI, Haber E, Barger AC. Inhibition of angiotensin conversion and prevention of renal hypertension. Am J Physiol. 1975;228:448–453
  32. Taylor AT, Fletcher JW, Nally JV, Blaufox MD, Dubovsky E, Fine EJ, et al. Procedure guideline for diagnosis of renovascular hypertension (Society of Nuclear Medicine). J Nucl Med. 1998;39:1297–1302
  33. Fommei E, Ghione S, Hilson AJ, Mezzasalma L, Oei HY, Piepsz A, et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study (European Multicentre Study Group). Eur J Nucl Med. 1993;20:617–623
  34. Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006;47:1819–1836
  35. Taylor A, Nally J, Aurell M, Blaufox D, Dondi M, Dubovsky E, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension (Radionuclides in Nephrology Group. Consensus Group on ACEI Renography). J Nucl Med. 1996;37:1876–1882
  36. Claveau-Tremblay R, Turpin S, De Braekeleer M, Brassard A, Leblond R. False-positive captopril renography in patients taking calcium antagonists. J Nucl Med. 1998;39:1621–1626
  37. Postma CT, van Oijen AH, Barentsz JO, de Boo T, Hoefnagels WH, Corstens FH, et al. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Intern Med. 1991;151:1531–1535
  38. Svetkey LP, Himmelstein SI, Dunnick NR, Wilkinson RH, Bollinger RR, McCann RL, et al. Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension. 1989;14:247–257
  39. Krijnen P, van Jaarsveld BC, Steverberg EW, Man in't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;129:705–711
  40. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization (The Yale Vascular Center experience). Am J Hypertens. 1991;4:698S–705S
  41. Geyskes GG, de Bruyn AJ. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens. 1991;4:685S–689S
  42. House MK, Dowling RJ, King P, Gibson RN. Using Doppler sonography to reveal renal artery stenosis: an evaluation of optimal imaging parameters. Am J Roentgenol. 1999;173:761–765
  43. Meier GH, Sumpio B, Setaro JF, Black HR, Gusberg RJ. Captopril renal scintigraphy: a new standard for predicting outcome after renal revascularization. J Vasc Surg. 1993;17:280–285discussion 285–7
  44. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement?. Br J Radiol. 2003;76:220–231
  45. Gomez IS. Renovascular hypertension: pathophysiology and evaluation of renal function. In:  Lip H,  Hall E editor. Comprehensive Hypertension. Elsevier; 2007;p. 101–111
  46. Lerman LO, Rodriquez-Porcel M, Sheedy PF, Romero JC. Renal tubular dynamics in the intact canine kidney. Kidney Int. 1996;50:1358–1362
  47. Krier JD, Ritman EL, Bajzer Z, Romero JC, Lerman A, Lerman LO. Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol. 2001;281:F630–F638
  48. Daghini E, Juillard L, Haas JA, Krier JD, Romero JC, Lerman LO. Comparison of mathematic models for assessment of glomerular filtration rate with electron-beam CT in pigs. Radiology. 2007;242:417–424
  49. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation. 2002;106:1165–1171
  50. Daghini E, Primak AN, Chade AR, Krier JD, Zhu XY, Ritman EL, et al. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology. 2007;243:405–412
  51. Foley WD. Renal MDCT. Eur J Radiol. 2003;45:S73–S78
  52. Bentley MD, Lerman LO, Hoffman EA, Fiksen-Olsen MJ, Ritman EL, Romero JC. Measurement of renal perfusion and blood flow with fast computed tomography. Circ Res. 1994;74:945–951
  53. Itano NB, Sherrill LE, Lerman LO, Corica FA, Hauser MF, Romero JC, et al. Electron beam computerized tomography assessment of in vivo single kidney glomerular filtration rate and tubular dynamics during chronic partial unilateral ureteral obstruction in the pig. J Urol. 2001;166:2530–2535
  54. Lerman LO, Flickinger AL, Sheedy PF, Turner ST. Reproducibility of human kidney perfusion and volume determinations with electron beam computed tomography. Invest Radiol. 1996;31:204–210
  55. Feldstein A, Krier JD, Sarafov MH, Lerman A, Best PJ, Wilson SH, et al. In vivo renal vascular and tubular function in experimental hypercholesterolemia. Hypertension. 1999;34:859–864
  56. Lerman LO, Schwartz RS, Grande JP, Sheedy PF, Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol. 1999;10:1455–1465
  57. Rodriguez-Porcel M, Krier JD, Lerman A, Sheedy PF, Romero JC, Napoli C, et al. Combination of hypercholesterolemia and hypertension augments renal function abnormalities. Hypertension. 2001;37:774–780
  58. Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003;23:1295–1301
  59. Lerman LO, Taler SJ, Textor SC, Sheedy PF, Stanson AW, Romero JC. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int. 1996;49:846–854
  60. Juillard L, Lemoine S, Janier MF, Barthez PY, Bonnefoi F, Laville M. Validation of renal oxidative metabolism measurement by positron-emission tomography. Hypertension. 2007;50:242–247
  61. Szabo Z, Xia J, Mathews WB, Brown PR. Future direction of renal positron emission tomography. Semin Nucl Med. 2006;36:36–50
  62. Zhuang H, Duarte PS, Pourdehnad M, Li P, Alavi A. Standardized uptake value as an unreliable index of renal disease on fluorodeoxyglucose PET imaging. Clin Nucl Med. 2000;25:358–360
  63. Qiao H, Bai J, Chen Y, Tian J. Kidney modeling for FDG excretion with PET. Int J Biomed Imaging. 2007;2007:63234
  64. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med. 1995;36:1595–1601
  65. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med. 1991;32:665–672
  66. Cheung CM, Shurrab AE, Buckley DL, Hegarty J, Middleton RJ, Mamtora H, et al. MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney Int. 2006;69:715–722
  67. Akgun H, Gonlusen G, Cartwright J, Suki WN, Truong LD. Are gadolinium-based contrast media nephrotoxic? (A renal biopsy study). Arch Pathol Lab Med. 2006;130:1354–1357
  68. Bellin MF, van Der Molen AJ. Extracellular gadolinium-based contrast media: an overview. Eur J Radiol. 2008;66:160–167
  69. Nainani N, Panesar M. Nephrogenic systemic fibrosis. Am J Nephrol. 2008;29:1–9
  70. Hofmann L, Simon-Zoula S, Nowak A, Giger A, Vock P, Boesch C, et al. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int. 2006;70:144–150
  71. Mason RP. Noninvasive assessment of kidney oxygenation: a role for BOLD MRI. Kidney Int. 2006;70:10–11
  72. Egred M, Waiter GD, Al-Mohammad A, Semple SI, Redpath TW, Walton S. Blood oxygen level dependent (BOLD) MRI: a novel technique for the detection of myocardial ischemia. Eur J Intern Med. 2006;17:551–555
  73. Thoeny HC, Zumstein D, Simon-Zoula S, Eisenberger U, De Keyzer F, Hofmann L, et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology. 2006;241:812–821
  74. Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging. 2007;26:235–249
  75. Bartsch AJ, Homola G, Biller A, Solymosi L, Bendszus M. Diagnostic functional MRI: illustrated clinical applications and decision-making. J Magn Reson Imaging. 2006;23:921–932
  76. Welch WJ. Intrarenal oxygen and hypertension. Clin Exp Pharmacol Physiol. 2006;33:1002–1005
  77. Thurau K. Renal Na-reabsorption and O2-uptake in dogs during hypoxia and hydrochlorothiazide infusion. Proc Soc Exp Biol Med. 1961;106:714–717
  78. Cohen J. Renal metabolism of substrates in relation to renal function (Section 8: renal physiology). In:  Orloff B editors. Handbook of Physiology. Washington, DC: American Physiological Society; 1973;p. 909
  79. Giebisch G. Transport of sodium and chloride. In:  Boron WF,  Boulpaep EL editor. Medical Physiology. Philadelphia, Pennsylvania: Elsevier Saunders; 2005;p. 774
  80. Kiil F, Aukland K, Refsum HE. Renal sodium transport and oxygen consumption. Am J Physiol. 1961;201:511–516
  81. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation (I. Effects of diuretics). Am J Physiol. 1994;267:F1059–F1062
  82. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation. 1996;94:3271–3275
  83. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int. 2000;57:2080–2083
  84. Li LP, Storey P, Pierchala L, Li W, Polzin J, Prasad P. Evaluation of the reproducibility of intrarenal R2* and DeltaR2* measurements following administration of furosemide and during waterload. J Magn Reson Imaging. 2004;19:610–616
  85. Pedersen M, Dissing TH, Mørkenborg J, Stødkilde-Jørgensen H, Hansen LH, Pedersen JB, et al. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int. 2005;67:2305–2312
  86. Dos Santos EA, Li LP, Ji L, Prasad PV. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol. 2007;42:157–162
  87. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol. 2008;19:780–788
  88. Leong CL, Anderson WP, O'Connor PM, Evans RG. Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation. Am J Physiol Renal Physiol. 2007;292:F1726–F1733
  89. Evans RG, Leong CL, Anderson WP, O'Connor PM. Don't be so BOLD: potential limitations in the use of BOLD MRI for studies of renal oxygenation. Kidney Int. 2007;71:1327–1328author reply 1328
  90. Mason R. Response to “Don't be so BOLD: potential limitations in the use of BOLD MRI for studies of renal oxygenation”. Kidney Int. 2007;71:1328
  91. Kodibagkar VD, Cui W, Merritt ME, Mason RP. Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magn Reson Med. 2006;55:743–748
  92. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–2368
  93. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  94. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
  95. Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111:328–333
  96. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000;102:3074–3079
  97. Wolf K, Kurtz A, Pfeifer M, Höcherl K, Riegger GA, Krämer BK. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001;442:212–217

 Conflict of interest: none.

PII: S1933-1711(08)00172-1

doi: 10.1016/j.jash.2008.08.006

Journal of the American Society of Hypertension
Volume 3, Issue 1 , Pages 42-51 , January 2009

Article Tools